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Alcoholism
SubcorticalChronic alcohol abuse affects brain structure and function. We examined subcortical structure volumes in 77
short (6–15 week) and 90 long (multi-year) term abstinent alcoholics, along with 74 controls. We used a 3T
Siemens MPRAGE sequence for image acquisition and FSL FIRST software for measuring subcortical volumes.
When examining alcoholics without a comorbid stimulant disorder we found reduced hippocampal, pallidum
and thalamus volumes in short term abstinence compared to a non-substance abusing control sample with
numerically smaller yet still signiﬁcant reductions compared to controls in long term abstinence. When
examining alcoholics with a comorbid stimulant disorder, no difference from controls was found for any
subcortical volume. Alcoholics with a stimulant disorder had signiﬁcantly larger subcortical volumes than
alcoholics without a stimulant disorder.
This study replicates past research showing that chronic alcohol abuse is associated with lower subcortical
volumes in short-term abstinent chronic alcoholics and extends this ﬁnding, although with smaller effects
to long-term abstinent samples. The absence of this effect in the presence of a comorbid stimulant disorder
suggests either a protective effect of stimulant abuse/dependence or that the measurements reﬂect the ag-
gregate of alcohol dependence associated atrophy and stimulant abuse associated inﬂammation. Associations
with function suggest the second of these two alternatives.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license. 1. Introduction
Substantial changes in brainmorphologymark the stages of alcohol-
ism, including hazardous drinking, dependence, recovery and relapse
(Cardenas et al., 2007; Rohlﬁng et al., 2006). Magnetic resonance imag-
ing (MRI) has been extensively used to studymorphological changes in
subcortical structures that are associated with alcohol use disorders
(AUD) (Cardenas et al., 2011). Animal experiments (Bonthius et al.,
2001), human postmortem brain studies (Harding et al., 1997), and
human imaging studies (Agartz et al., 1999; Sullivan et al., 1995,
1996) all show that chronic heavy alcohol consumption damages the
hippocampus; additionally, changes in hippocampus-related functions
such as visuospatial learning and memory (Berthoz, 1997; Ghaem
et al., 1997; Hartley et al., 2007; Iaria et al., 2003; Lavenex et al., 2006;
O'Keefe, 1990; Santin et al., 2000) are among the most consistently
found consequences of chronic alcoholism in humans and in rodents
model (Beatty et al., 1996; Bowden, 1988; Corral-Varela and Cadaveira,, Inc., 1585 Kapiolani Blvd., Ste.
fax: +1 808 442 0015.
nc. Open access under CC BY license. 2002; De Renzi et al., 1984; Matthews and Morrow, 2000; Nixon et al.,
1987; Oscar-Berman and Ellis, 1987; Riege, 1987; Shelton et al., 1984).
Damaging effects on the hippocampus are believed to result from
the combined effects of ethanol-induced glucocorticoid elevation,
compromised nutrition, and oxidative stress. In previous research on
long-term abstinent alcoholics (LTAA) in our laboratory, (Sameti et al.,
2011) we did not ﬁnd reduced subcortical (including hippocampal)
volumes in LTAA, but did ﬁnd signiﬁcantly lower hippocampus
(and amygdala) volumes in multi-year abstinent alcoholics with
co-morbid psychiatric disorders.
Research has also focused on AUD disruption of brain reward
pathways (Koob, 1999; Koob and Kreek, 2007; Kreek and Koob,
1998; Makris et al., 2008; Wise, 1998), including prefrontal cortex
and the subcortical striatopallidal and extended amygdala systems.
Repeated chronic abuse and withdrawal of alcohol and drugs can
change one's hedonic set point (e.g., raising thresholds), increasing
substance dependence. Alcoholics have shown smaller volumes of
reward-related structures (nucleus accumbens and amygdala, along
with dorsolateral prefrontal cortex and anterior insula) compared to
non-alcoholic controls (Makris et al., 2008), with these smaller vol-
umes associated with impaired memory.
A hallmark of alcohol abuse is poor decision making with regard to
alcohol use. The Iowa Gambling Task (IGT) (Bechara et al., 1994), sim-
ulates real-life decisions with uncertain rewards and punishments.
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an inability to attach appropriate negative emotional valence to neg-
ative consequences. Currently active or recently detoxiﬁed alcoholics
have demonstrated impaired performance on the SGT (Bechara and
Damasio, 2002; Bechara et al., 2001; Mazas et al., 2000), and we
(Fein et al., 2004a) have shown persistent impaired performance on
the SGT in LTAA. We (Fein et al., 2006) found that multi-year absti-
nent alcoholics who were impaired on the SGT had bilaterally smaller
amygdala volumes compared to controls.
There is a body of research observing hypertrophy in basal subcorti-
cal structures in stimulant abusing individuals. Chang et al. (2005)
found larger putamen and globus pallidus in 50METHusers vs. controls.
In that study, METH users had normal cognitive function, and those
with smaller striatal structures had poorer cognitive performance and
greater cumulative METH usage. Jernigan and Gamst (2005) examined
the separate and combined effects of methamphetamine dependence
and HIV infection on brain morphology. They found that methamphet-
amine dependence was associated with basal ganglia and parietal
cortex volume increases, with neurocognitive impairment associated
with the methamphetamine dependence volume increases (a different
pattern of associations from the Chang paper). However, not all studies
of METH found enlarged subcortical volumes (see Chang et al.'s, 2007
review). Thompson et al. (2004) reported reduced hippocampal vol-
umes in chronic METH users. More recently, Ersche et al. (2011)
found that cocaine users had increased graymatter volumes in the cau-
date nucleus, and the ventral striatum. Ersche et al. (2012) also reported
gray matter medial-temporal lobe and basal ganglia volume increases
in both stimulant-dependent individuals and their non-drug abusing
siblings.
The purpose of the current studywas to examine subcortical volumes
in short-term and long-term abstinent pure alcoholics and alcoholics
with co-occurring stimulant abuse or dependence. We hypothesized
that we would see lower subcortical volumes in short-term abstinent
alcoholics without comorbid stimulant dependence, but not in those
with comorbid stimulant dependence. We hypothesized that such indi-
viduals would have alcohol dependence induced subcortical atrophy
masked by stimulant dependence induced subcortical inﬂammation.
We did not expect to see smaller subcortical volumes in long-term
abstinent individuals with alcohol dependence only, but might see
smaller hippocampal and amygdala volumes in such long-term absti-
nent with alcohol dependence only if they also had comorbid internal-
izing psychiatric disorders (as predicted from our prior study of
long-term abstinent alcoholics).2. Methods and materials
2.1. Participants
Short-term (6–15 week) abstinent alcoholics (STAA, n = 77), LTAA
(greater than 18 months abstinent, n = 90) and non-substance abus-
ing controls (NSAC, n = 74) were recruited from the island of Oahu
(Table 1). Abstinent alcoholics were recruited through advertisements
and ﬂiers posted in various treatment programs and 12-step recovery
meetings, and met DSM-IV-R lifetime criteria for alcohol dependence
(American Psychiatric Association, 1994). Forty-one STAA and 43
LTAA also met lifetime criteria for stimulant (cocaine and/or metham-
phetamine) abuse or dependence. For STAA, 12 had a cocaine disorder,
18 had a methamphetamine disorder, and 10 had both cocaine and
methamphetamine disorders. For LTAA, 19 had a cocaine disorder,
9 had a methamphetamine disorder, and 15 had both cocaine and
methamphetamine disorders. Subjects' substance use history was gath-
ered using the Lifetime Drinking History instrument with timeline
follow-back methodology (Skinner and Sheu, 1982), administered
separately for alcohol and for each other substance used. In addition,
subjects completed the computerized Diagnostic Interview Schedule(C-DIS) (Levitan et al., 1991) to ascertain externalizing, anxiety or
mood disorder diagnoses and symptom counts.
A breathalyzer test to screen for alcohol (Alco-Sensor IV, Intoximeters,
Inc., Saint Louis, MO) and a saliva screen for drugs (Oral Fluid Drug
Screen Device, Innovacon, Inc., San Diego, CA) was performed for all
subjects on each testing day, with negative ﬁndings required for partic-
ipation (no subjects failed screens). Participants received monetary
compensation for their participation. Exclusion criteria for all groups
included: a) signiﬁcant history of head trauma or cranial surgery;
b) current or lifetime history of diabetes, stroke, or hypertension that
required medical intervention; c) current or lifetime history of a signif-
icant neurological disorder; d) clinical or laboratory evidence of active
hepatic disease; e) clinical evidence forWernicke–Korsakoff syndrome,
and f) lifetime diagnosis of schizophrenia or schizophreniform disorder
(assessed by the C-DIS). For this current study, subjects with lifetime
dependence on opiates or marijuana were excluded.
2.2. Imaging data acquisition and analysis
MRIs were collected on a 3.0T Siemens Trio Tim platform, located
at the Queens Medical Center in Honolulu, HI. For each subject, we
acquired a sagittal T1-weighted (MPRAGE) image (TR = 2200 ms,
TE = 4.1 ms, TI = 1000 ms, acquisition matrix = 256 × 256) with
160 slices at 1.0 mm thickness and a Fluid Attenuated Inversion Re-
covery (FLAIR) image (TR = 9100 ms, TE = 83 ms, TI = 2500 ms,
acquisition matrix = 204 × 230) with 44 slices at 3 mm thickness.
A neuroradiologist read all MRI scans. All scans were free from abnor-
malities other than white matter signal hyperintensities (WMSH)
visualized on the FLAIR images. Subcortical hyperintensities were
identiﬁed on only a handful of subjects in the current study samples.
Wemeasured subcortical brain structures using FSL's FIRST software
(FMRIB Image Registration and Segmentation Tool) (Patenaude, 2007),
a method that has been used by us and others to successfully measure
subcortical volumes in a number of recent investigation (Angstrom
et al., 2004; Corthorn et al., 1997; Figueroa Cave, 1997; Goodro et al.,
2012; Markov et al., 1997; Rinehart et al., 1997; Sameti et al., 2011).
The following structures were extracted and their volumes measured
for all T1-weighted MR images: left and right thalamus, caudate,
putamen, pallidum, hippocampus, amygdala, and nucleus accumbens.
When boundaries of the delineated structures were visually inspected,
we observed boundary underestimation of lateral ventricles (and corre-
sponding overestimation of subcortical structures bordering on the lat-
eral ventricles) in MRIs of subjects with ventricles signiﬁcantly larger
than those in theMNI152 standard template. To ensure amore accurate
segmentation, MRIs were registered MNI152 standard space template
using FSL's FNIRT (FMRIB's Nonlinear Image Registration Tool). The
warped (registered)MRIswere then processed through FIRST to extract
the surfacemesh of each of the subcortical structures. The surfaceswere
then transformed back to the original MRI space, ﬁlled and boundary
corrected using the FSL tool “ﬁrst_utils” (preventing voxel overlap be-
tween structures). Boundaries of each structurewere visually inspected
for gross errors. Visual inspection also showed that subcortical volume
estimates were unaffected by subcortical hyperintensities, when
present. Each extracted structure wasmeasured in cubic millimeters.
Cranium size estimation (an estimate of premorbid brain size) was
also performed using FSL's SIENAX (Structural Image Evaluation,
using Normalization, of Atrophy) tool. We have previously shown
that the FSL cranium size index is an excellent surrogate for the
intracranial vault volume (Fein et al., 2004b).
2.3. Cognitive assessment
TheCambridgeAutomatedNeuropsychological Test Battery (CANTAB,
Cambridge Cognition Ltd.) was used for the cognitive assessment.
The following tests were administered to all participants: Affective
Go/No-go, Big/Little Circle, Delayed Matching to Sample, Intra-Extra
Table 1
Demographic and substance use measures.
STAA LTAA NSAC
DAO N = 36 DASD N = 41 DAO N = 47 DASD N = 43 N = 74
♂ N = 24 ♀ N = 12 ♂ N = 24 ♀ N = 17 ♂ N = 28 ♀ N = 19 ♂ N = 19 ♀ N = 24 ♂ N = 37 ♀ N = 37
Demographics
Age (yrs) 49 ± 7 50 ± 7 44 ± 6 43 ± 4 48 ± 7 50 ± 5 49 ± 8 49 ± 7 47 ± 7 49 ± 8
Years of education 14 ± 3 14 ± 3 13 ± 2 13 ± 2 14 ± 2 13 ± 2 14 ± 3 13 ± 2 16 ± 3 16 ± 3
Prop of 1st degree relative
problem drinkers
.27 ± .28 .45 ± .34 .26 ± .26 .41 ± .30 .28 ± .29 .40 ± .27 .23 ± .29 .41 ± .33 .13 ± .19 .23 ± .23
Prop of 1st degree relative
problem drug users
.12 ± .17 .12 ± .18 .22 ± .25 .34 ± .30 .14 ± .27 .18 ± .19 .16 ± .28 .31 ± .30 .03 ± .09 .05 ± .13
Alcohol use variables
Duration of alcohol use (mo) 353 ± 110 356 ± 95 333 ± 80 274 ± 66 299 ± 114 297 ± 111 293 ± 99 297 ± 118 252 ± 143 270 ± 145
Average alcohol dose (drinks/mo) 245 ± 265 109 ± 76 201 ± 150 165 ± 122 230 ± 185 215 ± 183 214 ± 154 154 ± 111 10 ± 9 8 ± 8
Duration of peak use (mo) 133 ± 111 92 ± 89 90 ± 89 56 ± 36 84 ± 76 83 ± 58 124 ± 111 118 ± 99 95 ± 67 84 ± 79
Peak dose (drinks/mo) 473 ± 552 228 ± 153 433 ± 229 377 ± 254 379 ± 293 377 ± 265 368 ± 258 293 ± 341 18 ± 15 17 ± 16
Abstinence duration (yrs) 67 ± 18 73 ± 20 75 ± 19 76 ± 23 2638 ± 2761 2847 ± 2587 2546 ± 2116 2997 ± 2416 N/A N/A
Stimulant use variables
Cocaine lifetime dose (g/mo) .03 ± .13 .19 ± .64 22 ± 45 5 ± 8 .4 ± 2.1 0 54 ± 111 21 ± 24 0 0
Cocaine peak dose (g/mo) .04 ± .2 .19 ± .64 38 ± 92 10 ± 13 .4 ± 2.1 0 72 ± 151 27 ± 28 0 0
Methamphetamine Lifetime Dose
(g/mo)
0 0 20 ± 35 29 ± 63 0 0 14 ± 21 14 ± 17 0 0
Methamphetamine peak dose
(g/mo)
0 0 24 ± 56 58 ± 168 0 0 17 ± 24 18 ± 20 0 0
Smoking variables
Lifetime nicotine dependence # (%) 89 84 70 71 74 63 100 76 11 16
Current nicotine dependence # (%) 90 89 43 47 30 53 42 57 0 5
Effect Size (partial η2)
STAA DAO
vs NSAC
STAA DASD
vs NSAC
STAA DAO vs
STAA DASD
LTAA DAO
vs. NSAC
LTAA DASD
vs. NSAC
LTAA DAO vs.
LTAA DASD
(STAA vs.
LTAA) DAO
Demographics
Age (yrs) 0.3 11.9⁎⁎⁎ 17.8⁎⁎⁎ 0.2 0 0.2 0
Years of education 9.4⁎⁎ 22.6⁎⁎⁎ 4.8 18.3⁎⁎⁎ 15.4⁎⁎⁎ 0 1.3
Prop of 1st degree relative problem drinkers 6.9⁎⁎ 13.5⁎⁎⁎ 2 11.4⁎⁎⁎ 11.5⁎⁎⁎ 0 0.1
Prop of 1st degree relative problem drug users 3.6 28.1⁎⁎⁎ 13.3⁎⁎⁎ 8.3⁎⁎ 15.2⁎⁎⁎ 2.2 0.9
Alcohol use variables
Duration of alcohol use (mo) 9.8a 2.8a 6.1⁎ 1.9a 1.6a 0 5.8⁎
Average alcohol dose (drinks/mo) 26.1a 49.4a 0.2 44.2a 52.5a 1.6 1.2
Duration of peak use (mo) 1.5a 1.3a 5.9a 0.2a 3.0a 4.3 2.5
Peak dose (drinks/mo) 24.3a 62a 0 49a 40.2a 0.7 0.1
Abstinence duration (yrs) 89.7a 89.3a 2.4a 38a 48.6a 0 28.6a
Stimulant use variables
Cocaine lifetime dose (g/mo) 0.7 8.7a 7.5a 0.9 12.6a 10.3a 0.1
Cocaine peak dose (g/mo) 0.9 6.7a 5.9a 0.9 12.4a 10.2a 0.1
Methamphetamine lifetime dose (g/mo) 0.5 13.7a 10.3a 0.6 26.6a 24.2a 0
Methamphetamine peak dose (g/mo) 0.5 7.3a 4.9a 0.6 27.1a 24.7a 0
Smoking variables
Lifetime nicotine dependence # (proportion) 4.3⁎ 11.3⁎⁎⁎ 1.6 11.9⁎⁎⁎ 20.7⁎⁎⁎ 1.1 1.6
Current nicotine dependence # (proportion) 10.7⁎⁎⁎ 11.7⁎⁎⁎ 0 11.1⁎⁎⁎ 14.2⁎⁎⁎ 0.4 0
LTAA, Long-Term Abstinent Alcoholics; NSAC, Nonsubstance Abusing Controls; STAA, Short-Term Abstinent Alcoholics; DAO, Dependent On Alcohol Only; DASD, dependent On
Alcohol With A Stimulant Disorder (abuse or dependence).
Effect is signiﬁcant:
⁎ p ≤ .05.
⁎⁎ p ≤ .01.
⁎⁎⁎ p ≤ .001.
a Statistical comparisons are invalid since this variable is related to the inclusion criteria.
49G. Fein, D. Fein / NeuroImage: Clinical 3 (2013) 47–53Dimensional Shift, Spatial Recognition Memory, Spatial Working
Memory, Motor Screening, Matching to Sample, and Reaction Time.
2.4. Statistical analysis
The General Linear Model (GLM) (SPSS Inc., 2009) was ﬁrst used to
determinewhether subcortical volumeswere correlatedwith the crani-
um size index. Since all subcortical volumes were signiﬁcantly positive-
ly correlated with the cranium size, we used linear regression to adjusteach structure volume for the cranium size index. For each subcortical
structure, we then added the left and right volumes, resulting in 7 cra-
nium size adjusted volumes per subject. We compared NSAC to STAA
DOA (dependent on alcohol only), STAA DASD (dependent on alcohol
with a co-occurring stimulant disorder), and to both LTAA DAO and
LTAA DASD. We also compared STAA DAO with STAA DASD and LTAA
DAO with LTAA DASD. For each of these analyses, we ﬁrst performed
a multivariate analysis across the seven subcortical volumes. Control
for multiple comparisons was accomplished using a variant of Fisher's
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50 G. Fein, D. Fein / NeuroImage: Clinical 3 (2013) 47–53protected t-test, where comparisons of individual structures were only
examined if the multivariate test across structures was signiﬁcant.
Partial eta squared was used as the measure of effect size. Partial eta
squared measures the percent of variance of the dependent variable
that is independently accounted for by the independent variable.
We examined the associations (separately for STAA DAO, STAA
DASD, LTAA DAO, and LTAA DASD) between subcortical volumes
and measures of alcohol, stimulant, and nicotine use (including days
abstinent), and with mood and anxiety diagnoses using Spearman
correlations. We also examined associations with subcortical volumes
of CANTAB tests that showed impairments in STAA vs. NSAC (Affective
Go/No-go, Delayed Matching to Sample, Motor Screening, and both
Spatial Recognition Memory and Spatial Working Memory), and com-
pared STAA DAO with STAA DASD on those CANTAB tests.
3. Results
3.1. Demographics
Table 1 presents the demographics for the study. The study groups
and (within STAA and LTAA) DAO and DASD were comparable on age
and did not differ on any alcohol use measure nor on the prevalence
of psychiatric comorbidities (Fein, in press). DAO and DASD differed
on age of alcohol dependence diagnosis, with individuals with alcohol
dependent individuals with a lifetime stimulant disorder meeting
criteria for alcohol dependence 5–7 years earlier than those without
a lifetime stimulant disorder (F1,71 = 16.5, p b .0001, es = 18.8%
for STAA and F1,86 = 10.6, p = .002, es = 11.0% for LTAA).
3.2. Subcortical volumes
Table 2 and Fig. 1 present the subcortical volume data.
STAA DAO vs. NSAC: Comparing NSAC and STAA DAO, the multivar-
iate test was highly signiﬁcant (Wilks' λ7,100 = 0.79, p b .001), with
smaller volumes in STAA DAO for the accumbens (F1,106 = 8.95,
p b .003, es = 7.8), hippocampus (F1,106 = 16.58, p = .001, es =
13.5), and pallidum (F1,106 = 9.10, P = .003, es = 7.0), and slightly
larger volumes for the thalamus(F1,106 = 3.94, p = .05, es = 3.6).
Including age as a covariate did not change the results.
STAA DASD vs. NSAC: Comparing NSAC and STAA DASD, the mul-
tivariate test was not signiﬁcant (Wilks' λ7,105 = 0.91, p N 0.20).
STAA DAO vs. STAA DASD: Comparing STAA DAO and STAA DASD,
the multivariate test was signiﬁcant (Wilks' λ7,67 = 0.81, p = .047),
with larger volumes in STAA DASD for the accumbens (F1,73 = 7.06,
p = .010, es = 8.8), amygdala (F1,73 = 4.85, p = .031, es = 6.2),
caudate (F1,73 = 6.15. p = .015, es = 7.8), hippocampus (F1,73 =
11.23, p b .001, es = 13.3), and thalamus(F,1.73 = 5.28, p = .024,
es = 6.7). Including age as a covariate did not change the results.
LTAA DAO vs. NSAC: Comparing NSAC and LTAA DAO, the multi-
variate test was marginally signiﬁcant (Wilks' λ7,111 = 0.887, p =
.059), with smaller volumes in LTAA DAO for the accumbens
(F1,117 = 4.17. p = .043, es = 3.4), hippocampus (F1,117 = 6.41,
p = .013, es = 5.2), pallidum (F1,117 = 5.08, p = .026, es = 4.2),
putamen (F1,117 = 4.92, p = .028, es = 4.0),and thalamus(F1,117 =
4.90, p = .029, es = 4.06). Including age as a covariate did not change
the results.
LTAA DASD vs. NSAC: Comparing NSAC and LTAA DASD, the mul-
tivariate test was not signiﬁcant (Wilks' λ7,107 = 0.927, p N 0.30).
LTAADAOvs. LTAADASD: Comparing LTAADAOand LTAADASD, the
multivariate test was not signiﬁcant (Wilks' λ7,80 = 0.937, p N 0.60).
STAA DAO vs. LTAA DAO: Comparing STAA DAO and LTAA DAO, the
multivariate test was not signiﬁcant (Wilks' λ7,73 = 0.872, p N 0.17).
The same was true comparing STAA DASD and LTAA DASD (Wilks'
λ7,74 = 0.940, p N 0.68).
Cocaine vs. methamphetamine disorders: Within STAA and LTAA,
we compared subcortical volumes between subjects with a cocaine
Fig. 1. Volumes and effect sizes of the seven subcortical structures for the various subject groups. Abbreviations: LTAA, Long-Term Abstinent Alcoholics; NSAC, NonSubstance
Abusing Controls; STAA, Short-Term Abstinent Alcoholics; DAO, Dependent on Alcohol Only; DASD, Dependent on Alcohol with a Stimulant Disorder (abuse or dependence).
51G. Fein, D. Fein / NeuroImage: Clinical 3 (2013) 47–53disorder to those with a methamphetamine disorder, excluding indi-
viduals with both cocaine and methamphetamine disorder. For STAA,
there were no differences between those with the two types of disor-
der (Wilks' λ7,23 = 0.715, p N 0.29). For LTAA, there was a trend
toward a signiﬁcant difference between those with the two types of
disorder (Wilks' λ7,20 = 0.548, p = 0.063), with lower volumes for
cocaine disorder vs. methamphetamine disorder individuals for the
accumbens, hippocampus and thalamus (all p's b 0.05).
3.3. Association of subcortical volumes with substance use and
psychiatric diagnoses
For alcohol, cocaine and methamphetamine, lifetime and peak use
and dose are highly intercorrelated (all r's N0.85). Lifetime and peak
use measures for cocaine and alcohol are also signiﬁcantly correlated(r = 0.254 and r = 0.216, both p's b 0.05). Methamphetamine use
measures were not correlated with either alcohol or cocaine use mea-
sures (all |r| b 0.13, all p's N 0.22). In STAA DAO, accumbens, caudate,
and thalamus volumes were negatively associated with alcohol use
(r's between −0.328 and −0.376, p's b .050, uncorrected for multi-
ple comparisons). There was no signiﬁcant subcortical volume by
alcohol use associations in LTAA DAO or in either STAA or LTAA
DASD. There were no associations of cocaine or methamphetamine
use measures with subcortical volume measures in either STAA or
LTAA DASD. Within the combined alcoholic groups, there were no
associations of any subcortical volume measures with nicotine use
measures (Wilks' λ7,75 = 0.91, p N .41). There were no associations
of days abstinent from alcohol or any drug within any group. There
were no associations of subcortical volumes with lifetime or current
total psychiatric, mood, anxiety, or internalizing diagnoses.
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Comparing DAO and DASD (combined STAA and LTAA) on the
cognitive measures that showed impairment in STAA vs. NSAC, the
multivariate test was not signiﬁcant (Wilks' λ9,154 = 0.949, p N 0.51).
The only signiﬁcant correlations of subcortical volumes with CANTAB
tests were negative associations in STAA DAO of accumbens and
putamen volumes with that were of the accumbens and putamen with
reaction time to targets on the Affective Go/No-go Task (r = − .341
and− .330, both p's b 0.05, uncorrected for multiple comparisons).
4. Discussion
There are three major and three minor ﬁndings in this paper. First,
we found smaller subcortical volumes for the accumbens, hippocam-
pus, and pallidum in STAA DAO vs. NSAC. Second, we found smaller
subcortical volumes of the same structures (plus the putamen) in
LTAA DAO vs. NSAC, with the size of the differences from NSAC
being consistently (but not signiﬁcantly) smaller for LTAA compared
to STAA. Third, we did not observe any differences from NSAC for
either STAA DASD or LTAA DASD. For STAA, DASD evidenced larger
volumes than DAO for the accumbens, hippocampus, pallidum, puta-
men and thalamus. Within LTAA, there were no signiﬁcant differ-
ences in subcortical volumes between those DAO and those DASD.
Fourth, within STAA DAO, subcortical volumes were moderately neg-
atively correlated with alcohol use, but no associations with cocaine,
methamphetamine, or nicotine use measures nor with days abstinent
on alcohol, stimulants or nicotine was evident in any group. Fifth,
alcoholics DAO and DASD (combined STAA and LTAA) did not differ
on any cognitive measures that showed impairment in STAA vs. NSAC.
Finally, in LTAA, individuals with a cocaine disorder had lower volumes
of the accumbens, hippocampus and thalamus than those with a meth-
amphetamine disorder, suggesting that the inﬂammation secondary to
a cocaine disorder may resolve with long-term abstinence while that
due to a methamphetamine disorder does not.
4.1. Subcortical volumes are reduced in STAA DAO compared to NSAC
The smaller volumes were found in the accumbens, hippocampus,
and pallidum. The largest effect was for the hippocampus, consistent
with the literature on the morbid effects of chronic alcohol abuse on
hippocampal volumes and function (Agartz et al., 1999; Bonthius
et al., 2001; Harding et al., 1997; Sullivan et al., 1995, 1996). The
ﬁndings for the other regions are consistent with prior research show-
ing smaller volumes of reward-related subcortical structures in alco-
holics compared to controls (Makris et al., 2008; Oscar-Berman and
Song, 2011).
4.2. Subcortical volumes are reduced in LTAA DAO compared to NSAC
In our earlier study of LTAA recruited from the San Francisco Bay
Area, we did not ﬁnd a group (LTAA vs. NSAC) main effect for subcor-
tical volume. Our ﬁnding of such an effect (lower volumes in LTAA
vs. NSAC for the accumbens, hippocampus, pallidum, putamen and
thalamus) in the current study is likely due to a combination of both
sample differences and imaging protocol improvements in Oahu vs.
California. The current (Oahu) sample did not differ in age from the
California sample, but started drinking on average 1.5 years earlier
(14.4 ± 4.0 vs. 15.8 ± 4.6 yrs; F1,155 = 5.0, p = 0.026, es = 3.1).
They also had much less education (13.6 ± 2.3 vs. 15.5 ± 2.1 yrs;
F1,155 = 25.0, p b 0.0001, es = 13.9), much higher body mass indices
(29.3 ± 5.4 vs. 25.9 ± 3.8; F1,155 = 17.5, p b 0.0001, es = 10.1), and
a trend toward greater alcohol doses (199.9 ± 156 vs. 157.3 ±
122 drinks/mo; F1,155 = 3.2, p = 0.078, es = 2.0). The imaging studies
onOahuwere carried out on a3.0Tmagnet vs. a 1.5Tmagnet in California,
with 5 year newer software and hardware in Oahu. LTAA in Oahu werenot as healthy as those in California (much higher BMI) andwere much
less highly educated than those in California, possibly indicating less
brain functional reserve capacity— both of these factors may have lim-
ited their capacity for recovery from the brain morbidity of alcoholism
(thus evidencing lower than NSAC subcortical volumes even after
multi-year abstinence). Additionally, their greater alcohol use may
have given them a greater alcohol brain morbidity burden to recover
from. Finally, the improved imaging protocol may have been more sen-
sitive in measuring the effects of alcoholism on subcortical structures.
We believe the major import of this result is that one cannot generalize
from one study of LTAA to the population of LTAA. LTAA cohorts may
differ in alcoholism severity and in their ability to recover from such
burden. Finally, given the cross-sectional nature of this study,we cannot
deﬁnitively state that differences between STAA and LTAA are the result
of differences in abstinence durations — the differences may be due
to some unmeasured cohort differences. Nonetheless, the similarity of
STAA and LTAA on demographic and alcohol use variables supports
the idea that differences between STAA and LTAA are a consequence
of differences in length of abstinence.
It is important to note that the differences in subcortical volumes
in LTAA DAO vs. NSAC were numerically (but not statistically) smaller
than the differences between STAA DAO and NSAC. The (numerically)
smaller differences are consistent with either partial recovery of sub-
cortical volumes with long-term abstinence or with selective survi-
vorship (i.e., STAA with less subcortical volume loss are more likely
to survive to long-term abstinence). These alternative hypotheses
can only be decided between with an adequately powered longitudi-
nal study. The lack of a statistically signiﬁcant difference between
subcortical volumes in STAA DAO and LTAA DAO is consistent either
with no recovery of subcortical volumes with long-term abstinence
or with inadequate power of the test of differences. Once again, this
speaks to the need for adequately powered longitudinal studies.
4.3. The effect of comorbid stimulant abuse/dependence on subcortical
volumes in STAA and LTAA
STAA or LTAA with comorbid stimulant dependence had subcortical
volumes which did not differ from NSAC. In STAA, DASD showed larger
subcortical volumes than DAO; in LTAA, no such differences were
evident, yet the lower volumes in LTAA DAO vs. NSAC were no longer
present in LTAA DASD. This set of results is consistent with either
of the two hypotheses. In the ﬁrst hypothesis, comorbid stimulant
abuse/dependence protects individuals from alcohol dependence in-
duced atrophy. In the second hypothesis, comorbid stimulant abuse/
dependence causes inﬂammation of the already atrophied tissue,
masking the effects of alcohol dependence induced subcortical atrophy,
with the inﬂammatory effect diminishing with long-term abstinence.
Our cognitive data is highly supportive of the inﬂammation hypothesis.
If stimulants were protective, wewould have expected alcoholics DASD
to show less cognitive impairments than alcoholics DAO – the results
showed DASD evidenced numerically (but not statistically) more im-
pairment than DAO. The lack of associations of subcortical volumes
with cognitive performance measures in STAA DAO is consistent with
subjects DAO having reached a threshold of subcortical volume reduc-
tion that negatively impacts cognitive function.
4.4. Limitations of the current study
There are four major limitations of this study: First, it is observa-
tional rather than experimental. We can't be sure that the differences
between samples DAO and DASD have to do with the abuse of stimu-
lants rather than some unmeasured cohort differences between the
samples. Experimental studies of addiction (where subjects are ran-
domly assigned to alcohol only or alcohol and stimulants) are only
possible with animals, which have their own inherent limitations,
especially in studies of abstinence (where the human condition
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Nonetheless, the demographic similarity between alcoholics DAO
and DASD suggests that the differences between groups are likely
the result of stimulant abuse. Second, the study is cross-sectional
rather than longitudinal, which limits our ability to deﬁnitively attri-
bute differences between STAA and LTAA to duration of abstinence.
This limitation was discussed above. Third, STAA were abstinent a
minimum of six weeks. The study is therefore silent with regard to
subcortical volume effects of alcohol and stimulant abuse and depen-
dence in very early abstinence. This might be particularly relevant to
our lack of ﬁnding any associations of subcortical volumes with days
abstinent in STAA. Such effects might be present in the ﬁrst days
and weeks of abstinence. Finally, we acknowledge that we did not
actually measure inﬂammation, but inferred it from the literature,
the lack of ﬁndings on smaller subcortical volumes in the alcoholic
samples DASD, and the comparable or greater severity of functional
impairments in alcoholics DASD vs. DAO. Inﬂammation and atrophy
could be more directly inferred from MR spectroscopy studies which
could measure subcortical neuronal markers (NAA) and metabolites
that reﬂect inﬂammation.
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